Complete Revascularization with Multivessel PCI for Myocardial Infarction

医学 传统PCI 心脏病学 心肌梗塞 经皮冠状动脉介入治疗 内科学 罪魁祸首 血运重建
作者
Shamir R. Mehta,David Wood,Robert F. Storey,Roxana Mehran,Kevin R. Bainey,Helen Nguyen,Brandi Meeks,Giuseppe Di Pasquale,José López-Sendón,David P. Faxon,Laura Mauri,Sunil V. Rao,Laurent J. Feldman,Philippe Gabríel Steg,Álvaro Avezum,Tej Sheth,Natalia Pinilla‐Echeverri,Raúl Moreno,Gianluca Campo,Benjamin Wrigley
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:381 (15): 1411-1421 被引量:912
标识
DOI:10.1056/nejmoa1907775
摘要

BACKGROUND: In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) of the culprit lesion reduces the risk of cardiovascular death or myocardial infarction. Whether PCI of nonculprit lesions further reduces the risk of such events is unclear. METHODS: We randomly assigned patients with STEMI and multivessel coronary artery disease who had undergone successful culprit-lesion PCI to a strategy of either complete revascularization with PCI of angiographically significant nonculprit lesions or no further revascularization. Randomization was stratified according to the intended timing of nonculprit-lesion PCI (either during or after the index hospitalization). The first coprimary outcome was the composite of cardiovascular death or myocardial infarction; the second coprimary outcome was the composite of cardiovascular death, myocardial infarction, or ischemia-driven revascularization. RESULTS: At a median follow-up of 3 years, the first coprimary outcome had occurred in 158 of the 2016 patients (7.8%) in the complete-revascularization group as compared with 213 of the 2025 patients (10.5%) in the culprit-lesion-only PCI group (hazard ratio, 0.74; 95% confidence interval [CI], 0.60 to 0.91; P = 0.004). The second coprimary outcome had occurred in 179 patients (8.9%) in the complete-revascularization group as compared with 339 patients (16.7%) in the culprit-lesion-only PCI group (hazard ratio, 0.51; 95% CI, 0.43 to 0.61; P<0.001). For both coprimary outcomes, the benefit of complete revascularization was consistently observed regardless of the intended timing of nonculprit-lesion PCI (P = 0.62 and P = 0.27 for interaction for the first and second coprimary outcomes, respectively). CONCLUSIONS: Among patients with STEMI and multivessel coronary artery disease, complete revascularization was superior to culprit-lesion-only PCI in reducing the risk of cardiovascular death or myocardial infarction, as well as the risk of cardiovascular death, myocardial infarction, or ischemia-driven revascularization. (Funded by the Canadian Institutes of Health Research and others; COMPLETE ClinicalTrials.gov number, NCT01740479.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yyf完成签到 ,获得积分10
1秒前
泥蝶完成签到 ,获得积分10
2秒前
海盐奶盖完成签到,获得积分20
2秒前
心中的楠楠完成签到 ,获得积分10
2秒前
阔达海雪完成签到,获得积分10
2秒前
侯伯军完成签到,获得积分10
2秒前
听话的八宝粥完成签到 ,获得积分10
3秒前
ARNAMO完成签到,获得积分10
3秒前
姣妹崽完成签到,获得积分10
3秒前
zzzz完成签到,获得积分10
4秒前
赤练仙子发布了新的文献求助10
4秒前
Jack_hao完成签到,获得积分10
4秒前
Kane完成签到,获得积分10
4秒前
4秒前
wjn完成签到,获得积分10
5秒前
等待昊强发布了新的文献求助10
5秒前
爱教育的张月亮完成签到,获得积分10
5秒前
超级冬瓜完成签到,获得积分10
5秒前
xuz发布了新的文献求助10
6秒前
汉堡包的应助被will采纳,获得10
6秒前
周少完成签到,获得积分0
6秒前
aajhajkahna的应助被guan采纳,获得10
6秒前
Winter完成签到,获得积分10
6秒前
7秒前
桥下完成签到,获得积分10
7秒前
8秒前
苗条哈密瓜完成签到,获得积分10
8秒前
科研通AI65的应助被Locker23采纳,获得10
8秒前
科研通AI6.3的应助被放手一搏采纳,获得10
8秒前
8秒前
科研通AI6.4的应助被刘先生采纳,获得10
8秒前
8秒前
8秒前
ww关闭了ww的文献求助
8秒前
灵活又幸福的胖完成签到,获得积分10
9秒前
DW的应助被YPHCC采纳,获得10
9秒前
顺心囧发布了新的文献求助30
9秒前
伶俐春天完成签到,获得积分10
9秒前
冉冉完成签到,获得积分10
9秒前
NeonFire完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180275
求助须知:如何正确求助?哪些是违规求助? 9570366
关于积分的说明 21810725
捐赠科研通 7776380
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479042